Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)413.50
  • Today's Change-12.90 / -3.03%
  • Shares traded413.24k
  • 1 Year change+20.52%
  • Beta0.7631
Data delayed at least 15 minutes, as of Nov 12 2024 16:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments155151140
Total Receivables, Net583581510
Total Inventory487512402
Prepaid expenses------
Other current assets, total45--0
Total current assets1,2691,2431,052
Property, plant & equipment, net1,6531,6241,370
Goodwill, net265270272
Intangibles, net343362404
Long term investments36427.94
Note receivable - long term5.774.305.25
Other long term assets------
Total assets3,8093,7643,331
LIABILITIES
Accounts payable217251200
Accrued expenses1109392
Notes payable/short-term debt000
Current portion long-term debt/capital leases426396289
Other current liabilities, total222196181
Total current liabilities974937763
Total long term debt612526543
Total debt1,037921832
Deferred income tax264222180
Minority interest505351
Other liabilities, total34166204
Total liabilities1,9341,9031,740
SHAREHOLDERS EQUITY
Common stock757676
Additional paid-in capital------
Retained earnings (accumulated deficit)1,8451,7571,520
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(45)29(5.38)
Total equity1,8751,8611,591
Total liabilities & shareholders' equity3,8093,7643,331
Total common shares outstanding277277277
Treasury shares - common primary issue3.684.404.89
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.